ToolGen (A199800) Stock Overview
A biotechnology company, focuses on the development of genome editing technology in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
A199800 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
The Market Is Sleeping on This Parkinson's Biotech - And I Think That's a Mistake
Gain Therapeutics: The Under-the-Radar Biotech With Big Parkinson’s Potential Key Takeaways Gain Therapeutics (GANX) is developing GT-02287 – an oral, first-in-class, potentially disease-modifying treatment for Parkinson’s disease targeting the GCase enzyme pathway. Parkinson’s disease represents a $4 billion U.S. market with zero approved disease-modifying therapies.Read more
ToolGen Incorporated Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩55,500.00 |
| 52 Week High | ₩82,900.00 |
| 52 Week Low | ₩26,650.00 |
| Beta | 1.16 |
| 1 Month Change | 21.84% |
| 3 Month Change | -6.41% |
| 1 Year Change | 91.71% |
| 3 Year Change | 14.79% |
| 5 Year Change | -44.39% |
| Change since IPO | 13.27% |
Recent News & Updates
Recent updates
ToolGen's (KOSDAQ:199800) Earnings Might Not Be As Promising As They Seem
Mar 28
Here's Why ToolGen (KOSDAQ:199800) Can Afford Some Debt
Mar 14Would ToolGen (KOSDAQ:199800) Be Better Off With Less Debt?
Nov 19ToolGen (KOSDAQ:199800) Has Debt But No Earnings; Should You Worry?
Aug 06We Think ToolGen (KOSDAQ:199800) Can Easily Afford To Drive Business Growth
Mar 28Shareholder Returns
| A199800 | KR Biotechs | KR Market | |
|---|---|---|---|
| 7D | -6.9% | -3.8% | 7.7% |
| 1Y | 91.7% | 35.5% | 125.9% |
Return vs Industry: A199800 exceeded the KR Biotechs industry which returned 35.5% over the past year.
Return vs Market: A199800 underperformed the KR Market which returned 125.9% over the past year.
Price Volatility
| A199800 volatility | |
|---|---|
| A199800 Average Weekly Movement | 11.6% |
| Biotechs Industry Average Movement | 11.4% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in KR Market | 15.9% |
| 10% least volatile stocks in KR Market | 4.5% |
Stable Share Price: A199800 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A199800's weekly volatility (12%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 80 | Young Ho Kim | www.toolgen.com |
ToolGen Incorporated, a biotechnology company, focuses on the development of genome editing technology in South Korea. The company develops clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 gene scissors for gene editing in eukaryotic cells. It is involved in patent monetization, treatment, and seed businesses.
ToolGen Incorporated Fundamentals Summary
| A199800 fundamental statistics | |
|---|---|
| Market cap | ₩508.01b |
| Earnings (TTM) | -₩36.76b |
| Revenue (TTM) | ₩1.31b |
Is A199800 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A199800 income statement (TTM) | |
|---|---|
| Revenue | ₩1.31b |
| Cost of Revenue | ₩188.53m |
| Gross Profit | ₩1.12b |
| Other Expenses | ₩37.88b |
| Earnings | -₩36.76b |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -4.09k |
| Gross Margin | 85.57% |
| Net Profit Margin | -2,814.07% |
| Debt/Equity Ratio | 2.9% |
How did A199800 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/04/08 16:02 |
| End of Day Share Price | 2026/04/08 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
ToolGen Incorporated is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.